Logo for Salarius Pharmaceuticals Inc

Salarius Pharmaceuticals Investor Relations Material

Latest events

Logo for Salarius Pharmaceuticals Inc

Q2 2022

Salarius Pharmaceuticals
Logo for Salarius Pharmaceuticals

Q3 2024

14 Nov, 2024
Logo for Salarius Pharmaceuticals

Q2 2024

7 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Salarius Pharmaceuticals Inc

Access all reports
Salarius Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancers with unmet medical needs. The company specializes in epigenetic-based treatments, aiming to inhibit key cancer-related pathways and improve patient outcomes. The company is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.